INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/02/2026
Back to search
Official data from USPTO
BIODRONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
07/02/2026
Trademark type
Combined
Nice classes
5
Filing date
08/09/2017
Registration date
08/28/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/14/2025
Last transaction
07/02/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
KR
Examiner
POWERS, ALEXANDER L
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "BIODRONE" in stylized form.
Holders and representatives
Holders
MDimune Inc.
Representatives
Ryan D. Artis Riverside Law LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for treating ulcers; vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for use in urology; anti-inflammatories; pharmaceutical agents affecting digestive organs; pharmaceutical preparations for the treatment of cancer; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; diagnostic preparations for medical or veterinary purposes; diagnostic reagents and contrast media for medical purposes; human vaccine preparations; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for medical diagnosis; anti-cancer preparations; tumor suppressing agents
Publications
History of USPTO decisions and trademark events.
31 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/13/2026
INPC
INVALIDATION PROCESSED
06/12/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
11/14/2025
C71T
CANCELLED SECTION 71
03/14/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/28/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/03/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/28/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/10/2018
FIMP
FINAL DISPOSITION PROCESSED
12/10/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/28/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
08/28/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/12/2018
PUBO
PUBLISHED FOR OPPOSITION
06/12/2018
GPNX
NOTIFICATION PROCESSED BY IB
06/08/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/23/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/23/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/23/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/04/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/30/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/30/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/30/2018
RFNT
REFUSAL PROCESSED BY IB
12/17/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/29/2017
RFRR
REFUSAL PROCESSED BY MPU
11/29/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/16/2017
CNRT
NON-FINAL ACTION WRITTEN
11/15/2017
DOCK
ASSIGNED TO EXAMINER
11/09/2017
MAFR
APPLICATION FILING RECEIPT MAILED
10/21/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/17/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/12/2017
Continuous trademark protection
Get notified about every new filing that threatens BIODRONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.